Obstetric cholestasis: Current opinions and management

Annals of the Academy of Medicine Singapore

Volumn 32, Issue 3, 2003, Pages 294-298

  Tan, Lay Kok ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Bile acids; Liver function tests; Obstetric cholestasis (OC); Pregnancy; Pruritis; Stillbirths; Ursodeoxycolic acid (UDCA)

Indexed keywords

BILE ACID; DEXAMETHASONE; S ADENOSYLMETHIONINE; STEROID HORMONE; URSODEOXYCHOLIC ACID; VITAMIN K GROUP;

CHOLESTASIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; FEMALE; FETUS MONITORING; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; LIVER FUNCTION TEST; OBSTETRIC CHOLESTASIS; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT COUNSELING; PREGNANCY; PRURITUS; REVIEW; STILLBIRTH;

EID: 0041733605     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Reid R, Ivey K J, Rencoret R H, Storey B. Fetal complications ofobstetric cholestasis. BMJ 1976; 1:870-2.
2. Laatikainen T, Ikonen E. Fetal prognosis in obstetric hepatosis. Ann Chir Gynaecol Fenn 1975; 64:155-64.
3. Lammert F, Marschall H U, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000; 33:1012-21.
4. Palmer D G, Eads J. Intrahepatic cholestasis of pregnancy: a critical review. J Perinat Neonatal Nurs 2000; 14:39-51.
5. Heinonen S, Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol 1999; 94:189-93.
6. Fisk N M, Storey G N. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 1988; 95:1137-43.
7. Johnston W G, Baskett T F. Obstetric cholestasis. A 14 year review. Am J Obstet Gynecol 1979; 133:299-301.
8. Shanmugam S, Thappa D M, Habeebullah S. Pruritus gravidarum: a clinical and laboratory study. J Dermatol 1998; 25:582-6.
9. Abedin P, Weaver J B, Egginton E. Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethn Health 1999; 4:35-7.
10. Reyes H, Gonzalez M C, Ribalta J, Aburto H, Matus C, Schramm G, et al. Prevalence of intrahepatic cholestasis in Chile. Ann Intern Med 1978; 88:487-93.
11. Eloranta M L, Heinonen S, Mononen T, Saarikoski S. Risk of obstetric cholestasis in sisters of index patients. Clin Genet 2001; 60:42-5.
12. Heinonen S, Eloranta M L, Heiskanen J, Punnonen K, Helisalmi S, Mannermaa A, et al. Maternal susceptibility locus for obstetric cholestasis maps to chromosome region 2p13 in Finnish patients. Scand J Gastroenterol 2001; 36:766-70.
13. Reyes H. Review: intrahepatic cholestasis. A puzzling disorder of pregnancy. J Gastroenterol Hepatol 1997; 12:211-6.
14. Reyes H, Baez M E, Gonzalez M C, Hernandez I, Palma J, Ribalta J, et al. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. J Hepatol 2000; 32:542-9.
15. Meng L J, Reyes H, Palma J, Hernandez I, Ribalta J, Sjovall J. Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy. J Hepatol 1997; 27:1029-40.
16. Bacq Y, Sapey T, Brechot M C, Pierre F, Fignon A, Dubois F. Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 1997; 26:358-64.
17. Jacquemin E, Cresteil D, Manouvrier S, Boute O, Hadchouel M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999; 353:210-1.
18. Milkiewicz P, Gallagher R, Eggington E, Kilby M, Weaver J B, Elias E. Obstetric cholestasis with elevated GGT: incidence, presentation and treatment. Hepatology 2001; 34:A364.
19. Dixon P H, Weerasekera N, Linton K J, Donaldson O, Chambers J, Egginton E, et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 2000; 9:1209-17.
20. Roncaglia N, Arreghini A, Locatelli A, Bellini P, Andreotti C, Ghidini A. Obstetric cholestasis: outcome with active management. Eur J Obstet Gynecol Reprod Biol 2002; 100:167-70.
21. Campos GA, Guerra F A, Israel E J. Effects of cholic acid infusion in fetal lambs. Acta Obstet Gynecol Scand 1986; 65:23-6
22. Williamson C, Gorelik J, Eaton B M, Lab M, de Swiet M, Korchev Y. The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intra-uterine fetal death death in obstetric cholestasis. Clin Sci (Lond) 2001; 100:363-9.
23. Gorelik J, Harding S E, Shevchuk A I, Koralage D, Lab M, de Swiet M, et al. Taurocholate induces changes in rat cardiomyocyte contraction and calcium dynamics. Clin Sci (Lond) 2002; 103:191-200.
24. Kenyon A P, Piercy C N, Girling J, Williamson C, Tribe R M, Shennan A H. Obstetric cholestasis, outcome with active management: a series of 70 cases. BJOG 2002; 109:282-8.
25. Milkiewicz P, Elias E, Williamson C, Weaver J. Obstetric cholestasis. BMJ 2002; 324:123-4.
26. Kenyon A P, Piercy C N, Girling J, Williamson C, Tribe R M, Shennan A H. Pruritus may precede abnormal liver function tests in pregnant women with obstetric cholestasis: a longitudinal analysis. BJOG 2001; 108:1190-2.
27. Walker I A, Nelson-Piercy C, Williamson C. Role of bile acid measurement in pregnancy. Ann Clin Biochem 2002; 39:105-13.
28. Lunzer M, Barnes P, Byth K, O'Halloran M. Serum bile acid concentrations during pregnancy and their relationship to obstetric cholestasis. Gastroenterology 1986; 91:825-9.
29. Angulo P. Use of ursodeoxycholic acid in patients with liver disease. Curr Gastroenterol Rep 2002; 4:37-44.
30. Laifer S A, Stiller R J, Siddiqui D S, Dunston-Boone G, Whetham J C. Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J Matern Fetal Med 2001; 10:131-5.
31. Reyes H, Sjovall J. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med 2000; 32:94-106.
32. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002; 36:525-31.
33. Palma J, Reyes H, Ribalta J, Iglesias J, Gonzalez M C, Hernandez I, et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992; 15:1043-7.
34. Palma J, Reyes H, Ribalta J, Hernandez I, Sandoval L, Almuna R, et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol 1997; 27:1022-8.
35. Diaferia A, Nicastri P L, Tartagni M, Loizzi P, Iacovizzi C, Di Leo A. Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int J Gynaecol Obstet 1996; 52:133-40.
36. Mazzella G, Rizzo N, Azzaroli F, Simoni P, Bovicello L, Miracolo L, et al. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology 2001; 33:504-8.
37. Almasio P, Bortolini M, Pagliaro L, Coltorti M. Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis. Drugs 1990; 40(Suppl 3):111-23.
38. Frezza M, Pozzato G, Chiesa L, Stramentinoli G, di Padova C. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. Hepatology 1984; 4:274-8.
39. Frezza M, Centini G, Cammareri G, Le Grazie C, Di Padova C. S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial. Hepatogastroenterology 1990; 37(Suppl 2):122-5.
40. Ribalta J, Reyes H, Gonzalez MC, Iglesias J, Arrese M, Poniachik J, et al. S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results. Hepatology 1991; 13:1084-9.
41. Floreani A, Paternoster D, Melis A, Grella P V. S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial. Eur J Obstet Gynecol Reprod Biol 1996; 67:109-13.
42. Nicastri P L, Diaferia A, Tartagni M, Loizzi P, Fanelli M. A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol 1998; 105:1205-7.
43. Hirvioja M L, Tuimala R, Vuori J. The treatment of intrahepatic cholestasis of pregnancy by dexamethasone. Br J Obstet Gynaecol 1992; 99:109-11.
44. Lutz E E, Margolis A J. Obstetric hepatosis: treatment with cholestyramine and interim response to steroids. Obstet Gynecol 1969; 33:64-71.
45. Riikonen S, Savonius H, Gylling H, Nikkila K, Tuomi A M, Miettinen T A. Oral guar gum, a gel-forming dietary fiber relieves pruritus in intrahepatic cholestasis of pregnancy. Acta Obstet Gynecol Scand 2000; 79:260-4.
46. Gylling H, Riikonen S, Nikkila K, Savonius H, Miettinen T A. Oral guar gum treatment of intrahepatic cholestasis and pruritus in pregnant women: effects on serum cholestanol and other non-cholesterol sterols. Eur J Clin Invest 1998; 28:359-63.
47. Kaaja R J, Kontula K K, Raiha A, Laatikainen T. Treatment of cholestasis of pregnancy with peroral activated charcoal. A preliminary study. Scand J Gastroenterol 1994; 29:178-81.
48. Alsulyman O M, Ouzounian J G, Ames-Castro M, Goodwin T M. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol 1996; 175:957-60.
49. Olsson R, Tysk C, Aldenborg F, Holm B. Prolonged postpartum course of intrahepatic cholestasis of pregnancy. Gastroenterology 1993; 105:267-71.